CompletedPhase 3NCT05180968
DIalysis Symptom COntrol-Pruritus Outcome Trial
Studying Uremic pruritus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Manitoba
- Principal Investigator
- David Collister, MD, PhD, DDSUniversity of Manitoba
- Intervention
- Nabilone 0.5 MG Oral Capsule(drug)
- Enrollment
- 14 target
- Eligibility
- 25 years · All sexes
- Timeline
- 2022 – 2023
Study locations (2)
- University of Alberta Hospital, Edmonton, Alberta, Canada
- Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
Collaborators
Population Health Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05180968 on ClinicalTrials.govOther trials for Uremic pruritus
Additional recruiting or active studies for the same condition.